BOSTON, MA—Rare, postinfarction ventricular septal defects (VSDs), which saw a worrisome resurgence during the COVID-19 pandemic, can effectively be treated surgically or percutaneously, with similar ...
Percutaneous closure can be described as a less-invasive surgical procedure used to treat patients with atrial septal defect (ASD) or patent foramen ovale (PFO). Since the utilization of percutaneous ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback